MINERVA SURGICAL INC (UTRS) Stock Analyst Earnings Estimates
NASDAQ:UTRS - Nasdaq - US60343F2056 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.77M 45.21% | 52.1M 37.94% | 50.29M -3.47% | 52.836M 5.06% | 60.792M 15.06% | 69.87M 14.93% | |
| EBITDA YoY % growth | -8.31M 53.73% | -18.52M -122.86% | -20.09M -8.48% | -17.948M 10.66% | -17.752M 1.09% | -19.732M -11.15% | |
| EBIT YoY % growth | -15.39M 21.64% | -29.14M -89.34% | -30.9M -6.04% | -29.089M 5.86% | -26.678M 8.29% | -28.658M -7.42% | |
| Operating Margin | -40.75% | -55.93% | -61.44% | -55.06% | -43.88% | -41.02% | |
| EPS YoY % growth | N/A | N/A | -23.60 60.75% | -4.15 82.41% | -2.95 28.99% | -2.86 3.11% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 86.23% | -0.72 69.83% | -0.75 24.52% | -0.71 11.85% | -0.74 -35.19% | -0.71 2.39% | -0.73 2.84% | -0.69 3.29% | -0.73 2.60% |
| Revenue Q2Q % growth | 14.178M 2.74% | 14.484M 15.59% | 15.457M 15.44% | 14.79M 23.56% | 16.014M 12.95% | 16.626M 14.79% | 17.754M 14.86% | 17.034M 15.17% | 18.462M 15.29% |
| EBITDA Q2Q % growth | -2.726M -148.51% | -3.333M 57.26% | -4.474M -41.57% | -4.71M -2,843.98% | -5.235M -91.99% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.545M 12.43% | -6.296M 38.93% | -6.801M 11.21% | -6.528M -7.02% | -7.053M -55.18% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.81 89.88% | -1.02 | 0.21 | 20.59% |
| Q2 2023 Q2Q % growth | -1.00 75.00% | -1.84 | 0.84 | 45.53% |
| Q1 2023 Q2Q % growth | -2.40 68.42% | -2.24 | -0.16 | -6.95% |
| Q4 2022 Q2Q % growth | -4.00 -1,438.46% | -4.28 | 0.28 | 6.63% |
| Q3 2022 Q2Q % growth | -8.00 -264.27% | -5.71 | -2.29 | -40.06% |
| Q2 2022 Q2Q % growth | -4.00 | -6.94 | 2.94 | 42.33% |
| Q1 2022 Q2Q % growth | -7.60 | -6.32 | -1.28 | -20.31% |
| Q4 2021 Q2Q % growth | -0.26 | -0.30 | 0.04 | 12.85% |
| Q3 2021 Q2Q % growth | 4.87 | -0.45 | 5.32 | 1,185.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 11.97M -4.92% | 13.471M | -1.501M | -11.14% |
| Q2 2023 Q2Q % growth | 13.39M 3.24% | 14.2M | -810K | -5.70% |
| Q1 2023 Q2Q % growth | 12.53M 14.53% | 11.955M | 575K | 4.81% |
| Q4 2022 Q2Q % growth | 13.8M 1.10% | 14.08M | -280K | -1.99% |
| Q3 2022 Q2Q % growth | 12.59M 0.64% | 12.852M | -262K | -2.04% |
| Q2 2022 Q2Q % growth | 12.97M | 13.683M | -713K | -5.21% |
| Q1 2022 Q2Q % growth | 10.94M | 10.988M | -48K | -0.44% |
| Q4 2021 Q2Q % growth | 13.65M 0.74% | 13.723M | -73K | -0.53% |
| Q3 2021 Q2Q % growth | 12.51M 1.87% | 12.391M | 119K | 0.96% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1250% | 0% | -1750% |
| Revenue | 0% | -3.99% | 0% | -3.37% |